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Abstract
Background: Adolescence is a critical developmental stage when young people make lifestyle choices that have
the potential to impact on their current and future health and social wellbeing. The relationship between substance
use and criminal activity is complex but there is clear evidence that the prevalence of problematic substance use is
far higher among adolescent offenders than the general adolescent population. Adolescent offenders are a marginalized
and vulnerable population who are significantly more likely to experience health and social inequalities in later life than
their non-offending peers.
There is a paucity of evidence on effective interventions to address substance use and risk-taking behaviours in
adolescent offender populations but it is clear that preventative or abstinence orientated interventions are not
effective. RISKIT-CJS is an intervention developed in collaboration with young people taking account of the current best
evidence. Feasibility and pilot studies have found the intervention addresses the needs of adolescents, is acceptable
and has demonstrated potential in reducing substance use and risk-taking behavior.
Methods: The study is a mixed method, two-armed, prospective, pragmatic randomized controlled trial with individual
randomisation to either treatment as usual alone or the RISKIT-CJS intervention in addition to treatment as usual.
Adolescents, aged 13 to 17 years inclusive, engaged with the criminal justice system who are identified as having
problematic substance use are eligible to participate. The study will be conducted across three geographical areas;
South and South East England, London and North East England between March 2017 and February 2019.
Discussion: The study represents an ambitious programme of work to address an area of need for a marginalized and
vulnerable population.
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Background
Adolescence is a critical developmental stage when
young people make behavioural and lifestyle choices that
have the potential to impact on their current, and future,
health and wellbeing. While risk-taking is important for
healthy psychological development, for many, inappro-
priate risk-taking, often in the form of substance use such
as alcohol, illicit substances, legal highs and inappropriate
use of prescription medication, is associated with health
and social harm that can persist well into adulthood [1].
Adolescents are far more vulnerable to the negative
impact of substance use due to a range of psychological
factors that often interact and the differential effect of sub-
stances on the developing brain [2].
The relationship between substance use and criminal
activity is complex but it is clear that the prevalence of
substance use is higher in adolescent offending popula-
tions and the two are related in the context of other
forms of disinhibitory behavior such as aggression and
risk-taking [3]. Adolescents who offend experience a
range of complex risks and vulnerabilities including neg-
lect and abuse [4], substance use related problems, and
exclusion from education [5, 6]. As a group, they are
more likely to experience health and social inequalities
in later life, such as poor physical health [7], early preg-
nancy in females [8], higher rates of drug and alcohol
dependence [5, 6, 9], reduced employment opportunities
and economic hardship [10]. There is a widespread con-
sensus that adolescents who offend are one of the most
vulnerable and ‘hard to reach’ groups in the United
Kingdom [11], which has one of the highest youth cus-
tody populations in Western Europe [12]. In common
with other vulnerable populations adolescents in the
criminal justice system are more likely to access physical
and mental health services in times of crisis and this ac-
cess is often mediated through other agencies so identifi-
cation of those in need and early intervention strategies
should be proactive rather than reactive [9, 13, 14].
Recent data indicates that 14% of annual arrests in
England and Wales involved adolescents aged between
10 and 17 years, equating to 296 000 arrests. In 2012/13
there were almost 28 000 first time adolescent of-
fenders and the rate of recidivism in this population is
high at 36% [15]. The prevalence of problematic sub-
stance use is also high with 32% experiencing problems
associated with their use and 12% experiencing severe
problems [16].
The development of the RISKIT intervention [17],
and subsequently RISKIT-CJS, was based on two
streams of work; a thorough review of the research evi-
dence and a participative consultation with young people.
The theoretical perspective was informed by the Social
Development Model (SDM) [18–20]. This approach sug-
gests that the distal influences of socio-economic status,
biology, normative regulation and discipline are mediated
through proximal influences on behaviour which are iden-
tified as; perceived opportunities for pro- or antisocial
behaviour and perceived rewards for this behaviour. The
SDM marries the ecological context of young people’s
behaviour to an explanation of how this ecology influ-
ences their behaviour. It suggests that even in the absence
of a structural change to their health ecology, the
provision of socio-emotional and cognitive skills can help
young people prevent or reduce risk-taking behaviour and
also suggests that the building of bonds with organisations
promoting pro-social learning and opportunities is im-
portant in the reduction of risk-taking. The model pro-
vides a coherent and empirically validated approach that
suggests that intervention approaches should be multi-
component and encompass; knowledge and education,
cognitive and learning skills, self-efficacy and motivation.
The participatory consultation was adapted from par-
ticipatory action research [21, 22] and was carried out
with a number of groups of young people. The aim of
the exercise was to establish, with young people what
they perceived as risk-taking behaviour, why they took
risks, the consequences of taking risks and how they
perceived the problems could be addressed. The main
themes in terms of risk-taking behaviour centred around;
criminal activity, substance use and sexual activity and
these activities were considered as being linked. The par-
ticipants considered prevention programmes, that focus
on the negative outcomes of risk, failed to appreciate that
risk-taking can be positive and lead to positive outcomes,
an issue highlighted by other research exploring the pro-
cesses associated with risk-taking [18, 23]. The young
people highlighted the need for education regarding risks
and consequences associated with substance use, but par-
ticularly highlighted the preference for interventions that
provided skills and strategies to manage risk and the
opportunity to discuss these skills with peers and to learn
how to implement them. Interestingly parental influences
were not considered critical to any intervention and many
considered parental involvement would be inappropriate
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and unacceptable. The primary focus for the young people
was not on eradication of risk-taking but rather a focus on
how substance use and risk-taking could be reduced and
the negative consequences minimised.
We consulted a number of existing reviews and
research studies [24–29] and found that while there is a
growing body of research in the field there is a paucity
of rigorously evaluated interventions with the majority
of research arising from the US with limited applicability
to the UK. Of importance was what has been proven not
to work, this includes focusing on negative aspects of
risk and risk abstinence. Promising intervention ap-
proaches included motivational interviewing and cognitive
and socio-emotional life skills training. In addition there
was emerging recognition of the importance of providing
interventions in a structured manner and with the young
people’s preference for peer group interventions the
importance of managing the potentially negative effects of
labelling and peer influence.
Synthesis of the participatory group views, theoretical
underpinnings and the review of the evidence was
undertaken and the original RISKIT intervention model
developed as an approach that focuses on those who are
vulnerable to the negative consequences of their risk-
taking behaviour. The intervention combines individual
motivational interviewing sessions, to target motivation
and behaviour change with eight one hour group orien-
tated life skills sessions that covered a variety of areas;
identifying and managing risk, communication skills,
assertiveness training, anger management, preparing for
behaviour change, sexual health. In addition the group
sessions focused on identifying resources within the
community that could be of benefit for the young people
and provided opportunities to access these resources.
An initial feasibility study was undertaken followed by
a larger pilot study [17] in adolescents identified as
engaging in excessive risk-taking behaviour. Consent
rates in the eligible population were high, 80%, with
almost all attending at least part of the intervention and
74% attending all of the intervention sessions. Follow-up
rates were also high with 82% being followed-up at
6 months. Overall 32% of the intervention group had
reduced their risk-taking behaviour to a point where it
was of no further concern and the impact of the inter-
vention led to a greater reduction in substance use than
the control condition indicating a positive effect on this
domain. Participant views were positive with high levels
of engagement and satisfaction and a general view that
the intervention had been useful in developing new
skills, informative and had led to changes in behaviour.
Delivery of the model was sustainable but required the
input of specialist, rather than generic staff and a full
economic evaluation of cost-effectiveness was not under-
taken. Further to our pilot study the RISKIT intervention
has been modified for delivery in custodial and commu-
nity criminal justice populations, RISKIT-CJS. Assessment
of feasibility demonstrated high levels of satisfaction on
the part of the participants. Consent and engagement was
high with 90% consenting and almost 100% attending, in
part because the group intervention was provided over
two four-hour sessions over consecutive weeks, on week-
ends, rather than the 8 weekly one-hour sessions provided
in the pilot study.
The proposed study builds on the Medical Research
Council guidelines for the development and evaluation
of complex interventions. We have conducted research
to explore the theoretical validity of the intervention and
synthesized this theoretical approach with the current
evidence base and the views of potential participants in
order to model an appropriate intervention approach.
We have tested the feasibility of implementing the inter-
vention in the target population and refined the inter-
vention and its delivery as a result of that feasibility
study. We have conducted an appropriately designed
pilot study to explore potential effectiveness on the key
parameters and found evidence of potential effect in
reducing substance use and risk-taking behaviour and
high levels of satisfaction and engagement. As the pro-
posal involves a specific population, those engaged with
the criminal justice system rather than adolescents per
se, we have conducted a second feasibility study in this
population to assess feasibility and acceptability and
found high levels of engagement and acceptability in this
population. The next step is to conduct a rigorous
evaluation to address key outcomes in a way that
provides valid scientific evidence and is useful to those
engaged with this population and commissioners of ser-
vices. To this end we have proposed a full, multi-centre
randomized controlled trial, with an embedded qualita-
tive component, of the intervention versus treatment as
usual to explore the effectiveness of the intervention; in
reducing substance use and risk-taking behaviours, im-
proving mental-wellbeing, and reducing criminal activity
that is acceptable to participants and economically viable
to deliver.
Aims of the study
To evaluate the effectiveness and cost-effectiveness of
the RISKIT-CJS intervention compared with treatment
as usual in reducing substance use and related harms for
adolescents engaged with the criminal justice system.
Objectives
 To conduct a pragmatic prospective randomized
controlled trial to evaluate the effectiveness of the
RISKIT-CJS intervention compared with treatment
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as usual for substance using adolescents involved in
the criminal justice system.
 To evaluate the cost-effectiveness of the intervention
compared with treatment as usual.
 To explore participants, practitioners and criminal
justice staff experience, and acceptability, of the
intervention.
 To assess the fidelity of the intervention delivery
and explore the role of fidelity, therapeutic alliance
and baseline psychological factors on any outcomes
observed.
Methods and design
The trial has been granted ethical approval by the
University of Kent Ethics Committee (Ref: SRCEA169)
and will be conducted in accordance with the Declaration
of Helsinki between March 2017 and February 2019. A
Full flow diagram for the study is provided in Fig. 1.
Design
A mixed method, two-arm, prospective, pragmatic ran-
domized controlled trial with individual allocation.
Randomisation will be to either treatment as usual
alone or the RISKIT-CJS intervention in addition to
treatment as usual. The study will be conducted across
three geographical areas; South and South East England,
London and North East England.
Study hypotheses
The primary and secondary hypotheses, stated as null
hypotheses are;
 The RISKIT-CJS intervention is no more effective
than treatment as usual at 12-months post-
randomisation in reducing the frequency of
substance use in the previous 28-days.
 The RISKIT-CJS intervention is no more cost-
effective than treatment as usual at 12-months
post-randomisation.
Setting
Twenty-four Youth Offending Teams (YOT) across
England will be recruited (North-East n = 8, South-East
n = 8, London and the South n = 8). The sample is de-
signed to reflect variation in terms of social deprivation
and affluence, rural and urban, and culturally mixed
populations.
Participants
Inclusion criteria
Aged between 13 and 17 years inclusive, engaged with a
participating YOT, scoring 2 or more on the ASSET, or
equivalent, assessment for substance use.
Exclusion criteria
Severity of substance use requiring immediate referral to
specialist services for detoxification, known criminal
justice involvement likely to lead to incarceration during
the intervention or follow-up period, currently on an
order with substance use abstinence as a pre-requisite.
Randomisation
Randomisation will be conducted at the level of the par-
ticipant and by an independent, secure trial unit using
Fig. 1 Trial Flow diagram
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random permuted blocks of variable length. To allow for
the most efficient use of resources differential allocation
will be employed with twice as many participants allo-
cated to the control group compared with the interven-
tion group. Power calculations have been adjusted to
reflect the allocation ratio. Randomisation will include
stratification by gender, YOT and age group (13–15
years versus 16–17 years).
Sample size
The effectiveness analysis is designed to identify a clinically
important difference of 0.3 for the primary outcome meas-
ure, percent days abstinent from all substances at 12-
months post-randomisation. In order to detect an effect
size difference of 0.3, with alpha of 0.05 and 80% power
using a two-sided test requires 175 analysed at 12 months
in each of the two groups, a total of 350. As the interven-
tion is intensive and potentially costly to implement we
have increased the efficiency of the study by allocating par-
ticipants in a 2:1 ratio, with twice as many allocated to the
control condition. As differential allocation leads to a loss
of power we have maintained the integrity of the sample
size calculation by increasing the numbers required to
maintain power at 80%; 264 in the control group and 132
in the intervention group, a total of 396. Our previous
studies with adolescents and those involved in the criminal
justice system [30] suggests that loss at 12 months is likely
to be somewhere in the region of 15 to 30% and we have
adjusted the required sample to account for a 30% loss at
12 months. This inflates the required number consenting
to 567; 378 in the control group and 189 in the interven-
tion group. The optimal intervention group size is 8 par-
ticipants and we aim to deliver 24 RISKIT-CJS groups, 8
in each of the geographical areas.
The qualitative component of the study will be pur-
posive and include group discussion with participants in
the intervention group and individual interviews with
staff in participating YOT’s. Participants will be chosen
purposively in order to provide diversity in terms of site,
and age and ensure appropriate participation by gender,
social class and ethnicity. The sample size considerations
of the qualitative component are driven by the need to
achieve data saturation, the point at which no new
themes are emerging from the data, and this needs to be
judged in practice. Our previous experience of similar
studies would estimate the numbers groups of partici-
pants to be somewhere of the order of 12 groups and
the number of staff in YOT to be of the order of 24.
Interventions
RISKIT-CJS
RISKIT-CJS is delivered in 4 steps consisting of two
one-to-one sessions lasting approximately one hour each
and two half-day group sessions over two consecutive
weeks. Groups are delivered in mutually convenient
premises by trained and experienced practitioners in the
delivery of therapeutic interventions to young people, all
of whom are provided with training in the RISKIT-CJS
intervention and ongoing supervision and support. The
optimal group size is 6–8 participants.
The intervention involves four distinct steps. Step 1 en-
tails a single 60-min face-to-face session using motivational
interviewing approaches to explore current substance use,
risk-taking behaviour, and support for behaviour change
and enhance motivation to engage with the intervention.
This session is provided immediately after randomisation.
Step 2 involves a group session over half a day at a
location convenient for the participants. This session
uses a group CBT approach and addresses a number of
key issues involving both psycho-education and skill de-
velopment including; understanding substance use and
associated harms, understanding triggers of substance
use behaviour, strategies for managing and minimizing
risk-taking behaviour, strategies for diversion and dis-
traction and sexual health concerns.
Step 3 is conducted a week later at the same location
as step 2 and involves a similar group approach. At this
session issues covered include communication strategies
and assertiveness training, managing anger, using mind-
fulness and planning for the future.
Step 4 is a single one-to-one session using a motivational
interviewing approach that addresses outstanding barriers
to change, managing expectancy and enhancing self-
efficacy to change. At this stage interventionists work with
participants to identify local service contacts that may be
useful.
Training practitioners to deliver RISKIT-CJS
Experienced youth workers with prior training and
accreditation in providing motivational interviewing will
be trained using an existing training programme. The
training is provided over 2 days and covers; theoretical
underpinnings, delivering programme elements, managing
groups, individual motivational interviews, managing risks
and safeguarding. A full training and practice manual is
available for practitioners and senior practitioners will
observe practice and deem practitioners as competent
prior to embarking on the RISKIT-CJS programme.
Supervision is provided by senior staff with experience
of delivering the intervention on a regular basis
throughout the study period.
Control
Guidelines suggest that interventions should be provided
for adolescents within CJS settings who score 2 or more
on ASSET for substance use, but the reality is that there
exists no standard intervention approach with those who
have no immediate clinical need for treatment, in the
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form of detoxification or substitution. More often existing
services are signposted and rates of engagement are low
[14]. When intervention is provided it often takes the
form of short duration brief behavioural change interven-
tions with limited evidence of effectiveness in adolescent
substance using populations [31].
Outcome measures
Screening for substance use
ASSET is a standardized assessment tool, developed
within the criminal justice system in England and Wales,
which aims to identify the underlying causes of a young
person’s offending behaviour and to plan appropriate in-
terventions [32]. It is often used on multiple occasions
to help measure changes in young offenders’ health and
social needs and the risk of reoffending over time.
ASSET has been used with all young offenders in England
and Wales since 2000 and it examines 12 dynamic risk
factors; living arrangements, family and personal relation-
ships, education, neighbourhood, lifestyle; substance use,
physical health, emotional health, perception of self and
others, thinking and behaviour, attitudes to offending, and
motivation to change. The severity of each section is rated
on a 0–4 scale [32]. A score of 2 or more on the substance
use domain of ASSETT is indicative of substance use re-
lated problems that are associated with offending activity.
Primary outcome measure
Our primary outcome measure is percent days abstinent
from substance use in the 28-days prior to the 12-month
follow-up. This is measured using the Time-Line Follow
Back 28 day (TLFB28), a valid and reliable tool for asses-
sing the quantity and frequency of substance use over
time periods ranging from 1 to 365 days. The outcome
has been validated for use in adolescent populations [33]
and recent pilot work has indicated high levels of agree-
ment between the shorter, 28-day, and longer 90-day,
reference period. In addition to percent days abstinent
the tool allows derivation of a number of secondary out-
comes over the period; quantity and type of substances
consumed, sexual activity (planned, unplanned and re-
gretted) and incidences of self-harming behaviour. The
TLFB is completed by a trained member of research staff
and takes approximately 20 min. The outcome is mea-
sured at baseline, 6 and 12 months.
Secondary outcome measures
Mental health and wellbeing will be assessed using the
Warwick-Edinburgh Mental Well-being scale (WEMWBS).
WEMWBS is a 14-item, self-completed questionnaire ad-
dressing different aspects of eudemonic and hedonic men-
tal health wellbeing. The scale has established valid reliable
psychometric properties in adolescent populations [34]
and established sensitivity to change [35], the instrument is
highly correlated with other measures of psychological
health and well-being [36]. WEMWBS will be measured at
baseline and then again at 6 and 12 months.
The Strengths and Difficulties Questionnaire (SDQ)
[37] is a brief, 25-item, self-completed questionnaire
designed to explore common emotional and behavioural
difficulties in adolescent populations. In addition, the
questionnaire identifies the presence and severity of a
number of common mental health disorders in accord-
ance with ICD-10 criteria; conduct-oppositional, inatten-
tion, anxiety-depression [38]. The questionnaire has
established psychometric properties and performs well
when compared with other, more extensive tools. SDQ
will be assessed at baseline and then again at 6 and
12 months.
In order to assess potential prognostic factors, in
addition to demographics, that may impact on outcome
we will assess motivation to change, measured using the
Readiness to change questionnaire, (RCQ-TV) [39], and
self-efficacy, measured using the Brief Situational Confi-
dence Questionnaire, (BSCQ) [40] at baseline. Both instru-
ments are relatively short self-completed questionnaires
with established psychometric properties in the adolescent
population.
Economic outcome measures
The economic outcome measures will address the costs
of delivering the interventions, any change in health utility
in the 12 months after randomization and the service
costs associated with participants in the 12 months after
randomization. Costs associated with delivering the inter-
vention will be derived using a micro-costing approach ac-
counting for the actual costs including associated training,
facilities, overheads and management costs. Health utility
will be assessed using the self-completed 5-item EQ-
5D-5 L assessed at baseline, 6 and 12 months. Service
utilization on the part of the participant will be assessed
using a specifically designed client receipt service inven-
tory (CRSI) [41], currently being piloted with the adoles-
cent population. Service use will be assessed from a wide
public sector perspective encompassing health and social
care; criminal justice, education and employment service
utilisation.
Criminal justice outcomes will include arrests, charges
and convictions and will be derived from both Police
National Computer Systems and YOT Management
Information Systems. Data will be collected for all
offence types for the 12 months prior to and 12 months
after randomization.
Process outcome measures
The process of delivering the intervention may also play
a role in the outcomes observed in the intervention
group and we aim to assess this process using two
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distinct approaches. First, at the end each of the one-to-
one sessions we will ask each participant to complete
the Therapeutic Alliance Scale for Children (TASC-r;
[42]) a 12-item self-completed instrument with estab-
lished psychometric properties in the adolescent popula-
tion. Second a random sample of 20% of individual
motivational interviewing interventions, stratified by
centre, age and gender, will be recorded and assessed by
independent raters using the Behavioural Change Coun-
selling Index (BECCI; [43]) to assess fidelity and quality
of interventions delivered.
Procedure
Assessment of potential eligibility
All adolescents within YOT are routinely screened using
the ASSET tool or an equivalent and the results of the
screen are held on secure electronic records. Members
of the study team will liaise with YOT staff to identify po-
tential participants who meet the substance use eligibility
criteria and arrange a meeting at the YOT office between
potential participants and the RISKIT-CJS practitioner,
where possible this meeting will be scheduled to coincide
with existing commitments on the part of the participant.
Consent
Practitioners will meet with participants at the YOT office.
Eligibility will be assessed and those eligible provided with
a written and verbal description of the study and invited
to consider participating. If a participant is willing to par-
ticipate consent will be taken for those aged 16 or more or
those considered by the YOT staff as being ‘Gillick’ com-
petent. For those not considered competent to provide
consent caregivers will be contacted, provide with infor-
mation about the study and asked to provide informed
consent. Potential participants, whether consenting or
not, will be provided with a £10 voucher to compensate
them for their time.
Follow up assessment
Follow up will be conducted at 6 months and 12-
months post randomization and researchers will be
blind to participant allocation. Two weeks prior to the
6 and 12-month follow-up assessment participants will
be contacted by phone and post to make an appoint-
ment to carry out the follow-up assessment with the
option to complete the assessment by phone if no suit-
able location can be identified. The 6 and 12-month as-
sessment will be similar to the baseline assessment and
all participants will be provided with a £10 voucher to
compensate for their time and to reduce attrition in the
follow-up sample [44].
Qualitative data collection
Twelve RISKIT-CJS groups will be purposefully selected
according to geographical region and group dynamics,
and a group discussion will be conducted at the end of
step 3 of the intervention, the last group session
attended. The group discussion will be facilitated by an
individual with experience of participating in the RIS-
KIT-CJS intervention and observed by an experienced
qualitative researcher. The approach employed will be
Participatory Rapid Appraisal [45] to elicit in depth
exploration of the acceptability and perceived effectiveness
of the program and of the different elements within it.
In order to explore the RISKIT-CJS intervention from
the perspective of the practitioners, six semi-structured
phone interviews will be conducted, 2 weeks after the
final motivational interviewing intervention. The semi-
structured interviews and field notes maintained by
interventionists will be used to explore a number of key
objectives; feasibility, acceptability and perceived effective-
ness of the programme.
Telephone interviews will be carried out with a pur-
posively selected sample of YOT staff who are involved
with RISKIT-CJS programme, chosen according to pro-
fession and region. The aim is to explore the impact of
the RISKIT-CJS intervention from the perspective of the
YOT staff who work with the target population. There
will be 24 semi-structured telephone interviews with
staff across the participating teams. The Interviews will
be conducted 4 weeks after the final step four of the mo-
tivational interviewing intervention.
Analysis
Effectiveness analysis
Effectiveness analysis will be conducted by treatment
allocation using a two-sided 5% significance level. Ana-
lysis and results will be presented in accordance with
CONSORT guidelines. The primary outcome is percent
days abstinent from substance use in the 28-days prior
to the 12-month follow-up. After checking for distribu-
tional assumptions and making any appropriate transfor-
mations, this will be analysed using an analysis of
covariance adjusting for baseline values and stratification
values used in the randomisation process; age, gender
and YOT. Results will be presented as mean differences
between the groups and the associated 95% confidence
intervals. Missing data will be assessed using multiple
imputation approaches to model missing data scenarios,
and sensitivity analysis will be conducted to explore the
relative impact of missing data on the observed out-
come. Secondary outcomes will be modelled in a similar
manner.
Analysis will also be undertaken to model the relation-
ship between pre-randomisation factors and observed
outcomes at 12-months; demographics, self-efficacy,
Coulton et al. BMC Public Health  (2017) 17:246 Page 7 of 10
readiness to change. This analysis will employ a linear
regression model including interaction terms for rando-
mised group. To further enhance our understanding, we
will additionally incorporate an analysis of process by
enhancing the prognostic analysis through the inclusion
of measures of adherence, fidelity derived from the
BECCI ratings, and therapeutic alliance.
Exploratory sub-group analysis will be undertaken to
model the relationship between gender, ethnicity and
socio-economic status, measured using an index of ma-
terial deprivation from postcode on observed outcome.
Cost-effectiveness analysis
The effectiveness analysis will be complemented by an
economic evaluation that will evaluate the economic im-
plications of the intervention versus treatment as usual.
Substance use generates high costs for the individual,
health service and society in general and the economic
analysis will be conducted first using a narrow health
and social care perspective, to concord with National
Institute for Health and Social Care Excellence guide-
lines for the conduct of health economic evaluations;
and second using a wider public sector perspective in-
corporating costs associated with employment, training,
education and criminal justice.
The costs associated with identifying the eligible popu-
lation and delivering the interventions will be estimated
by prospectively monitoring local costs associated with
this activity and micro-costing training, management,
supervision, facilities and associated overheads. Data will
be extracted from study billing records. Impact on ser-
vice use on the part of the participant will be estimated
using a specifically designed CSRI and units of service
use valued using national unit costs.
The economic analysis will comprise cost-consequences
analysis (CCA) and incremental cost-effectiveness (CEA)
and cost-utility analyses (CUA). The CCA will report
mean and confidence intervals of: primary and secondary
outcomes as described above as well as QALYs gained,
costs per participant in each arm to health and social ser-
vices, the criminal justice system and society as a whole,
and differences between arms. The CEA will comprise cal-
culation of the incremental cost per incremental day free
of substance use, and the CUA, incremental cost per
QALY gained. QALYs will be calculated from EQ-5D-5 L
data converted to health state utilities using preference
weights specific to the UK population and integrated over
time. All analyses will be conducted over the time horizon
of 1 year. Analysis of uncertainty will comprise reporting
of standard errors and 95% confidence intervals around
increments and calculation of the cost-effectiveness
acceptability curve. Non-parametric bootstrapping will be
employed to investigate joint uncertainty in costs and ef-
fects and both one-way and multi-way sensitivity analysis
will be conducted to explore the impact of our basic
assumptions. The study will be conducted and reported in
accordance with good practice guidelines for health eco-
nomic evaluations [46].
Criminal justice outcomes
Criminal justice outcomes will be analysed using a com-
bination of linear and logistic analysis of covariance to
explore changes between groups and associated differ-
ences. A secondary analysis of CJS data will incorporate
baseline risk assessments to explore the potential inter-
vention effects on participant risk status.
Qualitative analysis
The aim of the qualitative component of the proposal is
to explore participants’ and practitioners’ experience of
the RISKIT-CJS intervention in order to generate infor-
mation pertaining to the feasibility, acceptability, con-
textual influences and mechanisms of action. The
qualitative design consists of two elements; the first is
participatory group work with participants who have ex-
perienced the RISKIT-CJS programme and the second
telephone interviews with practitioners who work with
these participants. Thematic coding of qualitative data
will be carried out using specific software (QSR NVIVO)
that allows for the coding of both verbal, transcripts and
field notes, and visual data. The coding allows for the
identification of recurrent and important themes and the
generation of a framework of themes relating to the key
research questions and objectives. A detailed description
of themes will be presented. Emergent themes that may
be explored from the quantitative data analysis will be
incorporated into the analysis plan as secondary explora-
tory analyses.
Discussion
There is a paucity of current research evidence regarding
effective interventions to address substance use, risk-
taking and related problems for adolescents engaged in
the criminal justice system. The current study builds on
a body of work that has developed a promising interven-
tion and piloted it with success in adolescent popula-
tions. The proposed study represents an innovative and
ambitious programme of work evaluating the RISKIT-
CJS intervention in reducing substance use in this popu-
lation. The study will inform theory and practice within
and beyond the UK and provide important information
on the effectiveness, cost effectiveness and implementa-
tion of interventions to address a recognized area of
need in a vulnerable and hard to reach population.
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